Stay updated with breaking news from Franco Moro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced
Stevanato Group (NYSE:STVN) announced today that its board of directors appointed Franco Stevanato as its new CEO.
STEVANATO GROUP S.P.A. ORDINARY SHAREHOLDERS' MEETING MAY 22, 2024 EXPLANATORY REPORT ON THE ITEMS ON THE AGENDA ...
STEVANATO GROUP S.P.A. NOMINATING AND CORPORATE GOVERNANCE COMMITTEE'S REPORT FOR 2023 2 ...
STEVANATO GROUP S.P.A. REPORT OF THE AUDIT COMMITTEE TO THE SHAREHOLDERS ON THE ACTIVITIES CARRIED OUT IN THE FINANCIAL YEAR 2023 ...